tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Holding TAK?
Track your performance easily

Takeda Pharmaceutical Company (TAK) Income Statement

1,235 Followers

Takeda Pharmaceutical Company Income Statement

Last quarter (Q4 2023), Takeda Pharmaceutical Company's total revenue was ¥―, a decrease of -100.00% from the same quarter last year. In Q4, Takeda Pharmaceutical Company's net income was ¥―. See Takeda Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 2.10T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T¥ 3.29T
Cost of Revenue
¥ 641.42B¥ 1.43T¥ 1.24T¥ 1.11T¥ 994.31B¥ 1.09T
Gross Profit
¥ 1.46T¥ 2.84T¥ 2.78T¥ 2.46T¥ 2.20T¥ 2.20T
Operating Expense
¥ 1.21T¥ 2.54T¥ 2.32T¥ 2.21T¥ 1.87T¥ 1.93T
Operating Income
¥ 251.43B¥ 298.50B¥ 295.38B¥ 251.12B¥ 338.31B¥ 274.71B
Net Non Operating Interest Income Expense
¥ -77.09B¥ -206.68B¥ 62.91B¥ 23.70B¥ -137.85B¥ -146.65B
Other Income Expense
¥ -2.64B¥ -11.28B¥ -333.81B¥ -27.76B¥ 165.77B¥ -188.81B
Pretax Income
¥ 171.70B¥ 52.79B¥ 692.11B¥ 532.63B¥ 366.24B¥ -60.75B
Tax Provision
¥ -9.18B¥ -91.41B¥ 58.05B¥ 72.41B¥ -9.94B¥ -105.04B
Earnings From Equity Interest Net Of Tax
-¥ 6.47B¥ -8.63B¥ -15.37B--
Net Income Common Stockholders
¥ 180.87B¥ 144.07B¥ 317.02B¥ 460.33B¥ 376.00B¥ 44.24B
Basic EPS
¥ 58.19¥ 92.09¥ 204.29¥ 147.14¥ 120.36¥ 14.21
Diluted EPS
¥ 57.55¥ 91.16¥ 201.94¥ 145.87¥ 119.48¥ 14.13
Basic Average Shares
¥ 6.25B¥ 1.56B¥ 1.55B¥ 1.56B¥ 3.12B¥ 3.13B
Diluted Average Shares
¥ 6.29B¥ 1.58B¥ 1.55B¥ 1.56B¥ 3.15B¥ 3.13B
Dividend Per Share
-¥ 0.94--¥ 90.35¥ 89.67
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----¥ 210.00-
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
¥ 1.85T¥ 3.97T¥ 3.73T¥ 3.32T¥ 2.86T¥ 3.02T
Net Income From Continuing And Discontinued Operation
¥ 180.87B¥ 144.07B¥ 317.02B¥ 460.33B¥ 376.00B¥ 44.24B
Normalized Income
¥ 180.87B¥ 36.45B--¥ 261.05B¥ 158.60B
Interest Expense
¥ 133.55B---¥ 130.81B¥ 149.01B
EBIT
¥ 305.25B¥ 206.42B¥ 492.06B¥ 410.20B¥ 497.04B¥ 88.26B
EBITDA
¥ 649.96B¥ 934.43B¥ 1.16T¥ 993.35B¥ 1.06T¥ 671.90B
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis